Jae-Seok Kim

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

D. Sze, D. Kirn, S. Han, 2008, The Lancet. Oncology.

Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes

T. Hwang, B. Park, Jae-Seok Kim, 2005, Cancer Gene Therapy.

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

D. Sze, D. Kirn, S. Han, 2008, The Lancet. Oncology.